Revela, Inc.
Oddity Labs, formerly Revela, is revolutionizing the beauty and wellness industry by applying pharmaceutical-grade AI and bioengineering for molecular discovery. They aim to overcome the stagnation in the sector, which often relies on reformulating legacy ingredients. By leveraging a sophisticated pipeline that includes robotic screening, medicinal chemistry, omic sequencing, in silico molecular screening, deep learning, and computational biology, Oddity Labs develops new molecules and biological modalities to address pressing challenges in thinning hair, aging skin, and nutrition. Their approach contrasts with traditional methods by reinventing, rather than rebranding, existing solutions, demonstrating safe and superior clinical efficacy. The company has a pipeline with over 200 patent-pending molecules, has screened over 1 billion molecules, and screens 25,000 molecules per second.
Revela, Inc.
Oddity Labs, formerly Revela, is revolutionizing the beauty and wellness industry by applying pharmaceutical-grade AI and bioengineering for molecular discovery. They aim to overcome the stagnation in the sector, which often relies on reformulating legacy ingredients. By leveraging a sophisticated pipeline that includes robotic screening, medicinal chemistry, omic sequencing, in silico molecular screening, deep learning, and computational biology, Oddity Labs develops new molecules and biological modalities to address pressing challenges in thinning hair, aging skin, and nutrition. Their approach contrasts with traditional methods by reinventing, rather than rebranding, existing solutions, demonstrating safe and superior clinical efficacy. The company has a pipeline with over 200 patent-pending molecules, has screened over 1 billion molecules, and screens 25,000 molecules per second.